Loading...
OTC: XTXXF
Adastra Holdings Ltd.
Healthcare · Drug Manufacturers - Specialty & Generic
Market Cap
$55.97K
52w High
$0.51
52w Low
$0.01
P/E
-0.08
Volume
100.00
Outstanding Shares
5.60M
Price vs Fundamentals
Why The Stock Is Moving
Likely fundamental deteriorationModerate confidence
Note: The most recent financial data is over 3 months old. Metrics shown may not reflect the latest reporting period.
1Y Price: -73.54%Revenue (TTM): -33.88%FCF (TTM): -96.28%
What changed
The stock fell 73.54% over the last year. Revenue declined 33.88% over the trailing twelve months. Operating margin moved from -0.78% to -14.42%. Free cash flow declined 96.28% over the trailing twelve months.
What the market seems to be pricing
The market appears to be responding to weaker operating momentum rather than only rerating the stock.
What would invalidate this read
Operating margin stands at -14.42%. Revenue declined 33.88% — this read reverses if that trend stabilizes. Free cash flow fell 96.28% — a return toward positive territory would undermine the deterioration thesis. If margins and cash flow stabilize while the stock stays depressed, the gap shifts from fundamental damage toward pure multiple compression.
Company profile
Adastra Holdings Ltd. operates as a cannabis extraction and processing solutions company.
CEOBrian O'Neill
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Employees—
IPO dateJul 19, 2021
Valuation
Forward P/E—
EV/EBITDA-0.22
Enterprise value$2.43M
Stock splits
Oct 15, 20241:10
Profitability & growth
Revenue growth-33.22%
Gross margin32.27%▲11.69%vs FY2023
Operating margin-14.42%▲51.54%vs FY2023
ROE-912.95%▼3682.29%vs FY2023
Analyst consensus
Rating—
Target price—
⚠ Analyst ratings tend to be lagging indicators — upgrades often follow price gains rather than precede them. Use as one signal among many.
Earnings
Last 3 reported quarters plus the next estimate. Switch into compare mode to inspect one metric year-over-year.
Next report
May 5, 2026
View
EPS
Actual vs estimate by quarter
Q4FY24
ActualEst.
-$1.50
—
Q2FY25
ActualEst.
-$0.09
—
Q4FY25
ActualEst.
-$0.06
—
Q1FY26
Next Est.
—
Revenue
Actual vs estimate by quarter
Q4FY24
ActualEst.
$3.29M
—
Q2FY25
ActualEst.
$3.14M
—
Q4FY25
ActualEst.
$3.4M
—
Q1FY26
Next Est.
—